Role Summary
Global Commercial Director T2D, CVRM β lead the launch strategy for a lead asset in Type 2 Diabetes and related cardiometabolic conditions, shaping pre-launch activities and aligning global and regional teams for launch readiness.
Responsibilities
- Lead development of a global go-to-market (GTM) strategy β including market segmentation, positioning, target audiences, and launch sequencing.
- Translate strategic objectives into an actionable global pre-launch roadmap, defining the value proposition, brand narrative, and engagement approach.
- Partner with regional and country commercial leaders to ensure global alignment and adaptability to local market realities.
- Create and socialize a clear brand strategy that balances scientific differentiation with emotional resonance across key stakeholders (HCPs, payers, patients, advocacy).
- Lead deep analysis of market dynamics, competitive environment, and evolving treatment paradigms to anticipate opportunities and risks.
- Partner with Insights, Analytics & Forecasting teams to generate actionable market and customer insights that inform TPP design, clinical plans, and launch assumptions.
- Develop and execute market-shaping initiatives β including awareness, disease-education, and early-access strategies β to create readiness ahead of launch.
- Build external validation loops through advisory boards, stakeholder mapping, and co-creation with key opinion leaders and advocacy groups.
- Partner closely with R&D, Clinical, Regulatory, Medical Affairs, Pricing & Market Access, and Global Product Teams to ensure the commercial voice is embedded early in development.
- Align global functions around clear pre-launch milestones (e.g., TPP validation, pricing strategy, access readiness, global narrative, and launch framework).
- Define and track KPIs to measure organizational readiness and strategic progress toward launch.
- Collaborate with regional/country teams to ensure knowledge transfer, toolkit development, and capability building for first-wave markets.
- Oversee creation of core global brand assets and messaging frameworks to ensure consistency across markets and channels.
- Manage relationships with creative and strategic agencies, consultants, and other third-party partners to develop pre-launch materials and campaigns.
- Lead development of the brand identity system β naming, tone of voice, and creative direction β in alignment with AstraZeneca standards and scientific integrity.
- Serve as a key member of the Global Commercial Leadership Team, ensuring transparency of strategy, timelines, and investment decisions.
- Present GTM recommendations, forecasts, and business cases to governance boards and senior leadership.
- Foster strong collaboration across functions and geographies; champion a culture of curiosity, accountability, and evidence-based decision making.
Qualifications
- Bachelorβs degree required; advanced degree (MBA, PhD, or MSc) preferred.
- 10+ years experience in pharmaceutical commercial strategy or marketing, ideally in pre-launch or early launch settings.
- Relevant experience in TA: cardiometabolic, obesity, or T2D
- Strong track record in developing and executing go-to-market or brand strategies that integrate insight generation, forecasting, and positioning.
- Proven ability to collaborate across scientific, regulatory, and commercial interfaces to drive alignment.
- Excellent analytical, strategic, and communication skills; comfortable influencing at senior levels in a matrixed environment.
- Self-starter with high energy, intellectual curiosity, and the ability to lead through ambiguity
Desirable Skills
- Experience in US or other large market
- Previous experience in global role
- Direct experience in market shaping, disease education, or pre-launch activation.
- Strong working knowledge of pricing, reimbursement, and access strategy.
- Familiarity with digital ecosystem development and omnichannel stakeholder engagement.